This bill (S 1979) requires healthcare providers in New Jersey to give parents or guardians access to minor patients' medical records related to reproductive health services (such as pregnancy care, contraception, or abortion), unless the minor objects. It applies specifically to services legal under New Jersey law and protects healthcare facilities and professionals from liability when providing this access. The law clarifies that parental access does not require written consent from the minor for these services, while maintaining existing privacy rules for other medical information. It directly affects parents/guardians of minors seeking reproductive health care and healthcare providers who serve them.
This bill establishes a state-funded program to support nursing transition-to-practice initiatives for licensed practical nurses (LPNs) and registered professional nurses (RNs) at healthcare facilities. It requires facilities to apply for NJCCN support to create structured 12-month programs with mentorship, full-time schedules, and data tracking, prioritizing veterans' homes, long-term care, and home care providers. The New Jersey Board of Nursing will allocate up to $2 million annually for financial, material, and technical assistance to approved facilities based on their applications. The bill also updates governance for the New Jersey Collaborating Center for Nursing (NJCCN), including board composition and appointment processes.
This bill (S 2540) amends New Jersey's pretrial release procedures to clarify that courts may require defendants to undergo mental health or substance abuse treatment as a condition of release. It specifies that courts must consider mental health treatment (under subsection i) alongside other non-monetary conditions - like curfews, employment requirements, or electronic monitoring - to ensure defendants appear in court and do not endanger others. The bill directly affects defendants facing pretrial detention who are deemed eligible for release but pose risks requiring structured supervision. It does not create new referral systems but refines existing release conditions to explicitly include treatment options for mental health/substance abuse issues. The bill is currently pending in the Senate Judiciary Committee.
S 2891 prohibits drug manufacturers, pharmacies, wholesalers, and healthcare providers from using devices, kiosks, or systems to steer patients to specific pharmacies or restrict their pharmacy choice when dispensing prescription drugs or samples. It requires explicit patient consent before transmitting personal health information to a particular pharmacy, with full disclosure of the patient’s right to choose their pharmacy or decline sharing information. Violations carry significant penalties: $100,000+ for companies per violation and $250+ for healthcare providers. The bill directly affects patients (by protecting their pharmacy choice), healthcare practitioners, and pharmaceutical entities. It aims to prevent restrictive marketing practices without altering existing authority for prescribing drugs.
This New Jersey Senate resolution (SR 23) urges Congress to require the U.S. Department of Health and Human Services (HHS) to comply with a 1986 federal law. The law mandates that HHS submit biennial reports to Congress detailing actions taken to improve vaccine safety, but HHS has failed to do so since the law's enactment. The resolution specifically calls for HHS to fulfill this reporting obligation as required by the National Childhood Vaccine Injury Act. It is a procedural measure with no new legal requirements, solely seeking to enforce an existing federal mandate.
This New Jersey bill (S 442) creates a role for county pretrial coordinators to help defendants on pretrial release access voluntary support services. It requires coordinators to evaluate defendants’ needs - including substance use treatment, food assistance (like SNAP), healthcare (Medicaid), housing, and job training - and connect them with appropriate programs during their release period. Counties must track service usage and outcomes, then report annually to the Governor and Legislature on whether these services affect rearrest rates. The bill applies to defendants charged with serious offenses or disorderly persons offenses who have been granted pretrial release, pending legislative approval.
This bill requires health insurance companies to provide small employers with at least 90 days' written notice before canceling or refusing to renew their stop loss insurance policies. Stop loss insurance protects small employers from unexpectedly high medical costs in self-funded health plans for their employees. The notice must be in a specific format set by the state insurance regulator, and the rule applies to policies issued or renewed 90 days after the bill becomes law. It directly affects small employers using self-funded health plans and their insurance providers in New Jersey.
This bill requires owners or operators of public community water systems in New Jersey to test for Legionella bacteria in drinking water. Specifically, they must test a random sample of 0.1% of service lines quarterly and 1% of water system facilities (like treatment plants and storage tanks) monthly. Test results must be reported to the Department of Environmental Protection (DEP), and if contamination exceeds DEP-established standards, the system must notify customers and remediate within 30 days (with full resolution required within six months). Violations would be enforced under the state's Safe Drinking Water Act, potentially resulting in civil penalties.
This bill (S 1972) lowers the required age for routine mammogram coverage from 40 to 35 for most women under New Jersey insurance plans. It requires all group and individual health insurance contracts (including hospital service, medical service, and health service corporation plans) to cover one baseline mammogram at age 35, followed by annual mammograms for women aged 35 and older. Women under 35 with family history or other breast cancer risk factors continue to receive coverage as deemed medically necessary by their provider. The law also maintains existing coverage for additional tests like ultrasounds or MRIs when medically indicated due to dense breast tissue or other risk factors. This change directly affects insurers and policyholders by expanding access to preventive breast cancer screening earlier.
This bill prohibits New Jersey's Department of Health (DOH) from creating health guidelines, rules, or regulations that are stricter than those set by federal agencies like the CDC or federal law. It directly affects the DOH by requiring all state health policies to match or be less strict than federal standards. The law applies to all administrative actions - including recommendations, directives, and regulations - and is retroactive to any existing state rules issued before the bill's effective date. This means the DOH must align its health policies with federal minimums, preventing New Jersey from implementing more protective measures.